194 related articles for article (PubMed ID: 27807213)
1. Tacrolimus Monotherapy after Intravenous Methylprednisolone in Adults with Minimal Change Nephrotic Syndrome.
Li X; Liu Z; Wang L; Wang R; Ding G; Shi W; Fu P; He Y; Cheng G; Wu S; Chen B; Du J; Ye Z; Tao Y; Huo B; Li H; Chen J
J Am Soc Nephrol; 2017 Apr; 28(4):1286-1295. PubMed ID: 27807213
[TBL] [Abstract][Full Text] [Related]
2. Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with
Medjeral-Thomas NR; Lawrence C; Condon M; Sood B; Warwicker P; Brown H; Pattison J; Bhandari S; Barratt J; Turner N; Cook HT; Levy JB; Lightstone L; Pusey C; Galliford J; Cairns TD; Griffith M
Clin J Am Soc Nephrol; 2020 Feb; 15(2):209-218. PubMed ID: 31953303
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
Li H; Shi X; Shen H; Li X; Wang H; Li H; Xu G; Chen J
Clin Ther; 2012 May; 34(5):1112-20. PubMed ID: 22503105
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus treatment after short-term intravenous methylprednisolone in incipient minimal change disease for adults: A retrospective analysis.
Shen Y; Sheng X; Zhang X; Dong Y; Zhai Y; Gao J; Chen Y; Gao G; Feng Y; Yin L; Wu X; Li R; Wang Y; Zhang H; Chen Z; Cheng G
Nephrol Ther; 2022 Nov; 18(6):549-556. PubMed ID: 36123282
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of intravenous methylprednisolone pulse versus oral prednisolone therapies on the first attack of minimal-change nephrotic syndrome in adults.
Fukudome K; Fujimoto S; Sato Y; Kitamura K
Nephrology (Carlton); 2012 Mar; 17(3):263-8. PubMed ID: 22117558
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
Li X; Li H; Chen J; He Q; Lv R; Lin W; Li Q; He X; Qu L; Suya W
Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Efficacy and Safety of Tacrolimus and Low-Dose Corticosteroid with High-Dose Corticosteroid for Minimal Change Nephrotic Syndrome in Adults.
Chin HJ; Chae DW; Kim YC; An WS; Ihm C; Jin DC; Kim SG; Kim YL; Kim YS; Kim YG; Koo HS; Lee JE; Lee KW; Oh J; Park JH; Jiang H; Lee H; Lee SK
J Am Soc Nephrol; 2021 Jan; 32(1):199-210. PubMed ID: 33168602
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus improves proteinuria remission in adults with cyclosporine A-resistant or -dependent minimal change disease.
Xu D; Gao X; Bian R; Mei C; Xu C
Nephrology (Carlton); 2017 Mar; 22(3):251-256. PubMed ID: 28035723
[TBL] [Abstract][Full Text] [Related]
10. An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study).
Rémy P; Audard V; Natella PA; Pelle G; Dussol B; Leray-Moragues H; Vigneau C; Bouachi K; Dantal J; Vrigneaud L; Karras A; Pourcine F; Gatault P; Grimbert P; Ait Sahlia N; Moktefi A; Daugas E; Rigothier C; Bastuji-Garin S; Sahali D;
Kidney Int; 2018 Dec; 94(6):1217-1226. PubMed ID: 30385039
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome.
Westhoff TH; Schmidt S; Zidek W; Beige J; van der Giet M
Clin Nephrol; 2006 Jun; 65(6):393-400. PubMed ID: 16792133
[TBL] [Abstract][Full Text] [Related]
12. Intravenous methylprednisolone pulse therapy in minimal change nephrotic syndrome.
Yeung CK; Wong KL; Ng WL
Aust N Z J Med; 1983 Aug; 13(4):349-51. PubMed ID: 6580858
[TBL] [Abstract][Full Text] [Related]
13. Favorable outcome of low-dose cyclosporine after pulse methylprednisolone in Japanese adult minimal-change nephrotic syndrome.
Matsumoto H; Nakao T; Okada T; Nagaoka Y; Takeguchi F; Tomaru R; Iwasawa H
Intern Med; 2004 Aug; 43(8):668-73. PubMed ID: 15468963
[TBL] [Abstract][Full Text] [Related]
14. Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome.
Imbasciati E; Gusmano R; Edefonti A; Zucchelli P; Pozzi C; Grassi C; Della Volpe M; Perfumo F; Petrone P; Picca M
Br Med J (Clin Res Ed); 1985 Nov; 291(6505):1305-8. PubMed ID: 3933645
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Steroid Therapy in Adult Minimal Change Nephrotic Syndrome: A Systematic Review and Meta-analysis.
Zhao L; Cheng J; Zhou J; Wu C; Chen J
Intern Med; 2015; 54(17):2101-8. PubMed ID: 26328632
[TBL] [Abstract][Full Text] [Related]
16. Comparison of methylprednisolone plus prednisolone with prednisolone alone as initial treatment in adult-onset minimal change disease: a retrospective cohort study.
Shinzawa M; Yamamoto R; Nagasawa Y; Oseto S; Mori D; Tomida K; Hayashi T; Izumi M; Fukunaga M; Yamauchi A; Tsubakihara Y; Isaka Y
Clin J Am Soc Nephrol; 2014 Jun; 9(6):1040-8. PubMed ID: 24721890
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy and safety of tacrolimus monotherapy and cyclophosphamide combined with glucocorticoid in the treatment of adult primary membranous nephropathy: protocol of a multicenter, randomized, controlled, open study.
Chen S; Ren S; Wang AY; Tran H; Li Z; Cheng X; Liu M; Li G; Wang L; Hong D
Trials; 2020 Feb; 21(1):219. PubMed ID: 32093742
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study.
Hu WX; Chen YH; Bao H; Liu ZZ; Wang SF; Zhang HT; Liu ZH
Lupus; 2015 Sep; 24(10):1067-75. PubMed ID: 25819933
[TBL] [Abstract][Full Text] [Related]
19. Minimal change nephrotic syndrome in adults: response to corticosteroid therapy and frequency of relapse.
Fujimoto S; Yamamoto Y; Hisanaga S; Morita S; Eto T; Tanaka K
Am J Kidney Dis; 1991 Jun; 17(6):687-92. PubMed ID: 2042651
[TBL] [Abstract][Full Text] [Related]
20. Short-Term Steroid Regimen for Adult Steroid-Sensitive Minimal Change Disease.
Ozeki T; Katsuno T; Hayashi H; Kato S; Yasuda Y; Ando M; Tsuboi N; Hagiwara D; Arima H; Maruyama S
Am J Nephrol; 2019; 49(1):54-63. PubMed ID: 30557879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
